Create issue ticket

144 Possible Causes for kirin, saz

  • Dementia

    Author information 1 Research Laboratories for Health Science & Food Technologies, Kirin Company Ltd, 1-13-5 Fukuura Kanazawa-ku, Yokohama-shi, Kanagawa 236-0004, Japan.[ncbi.nlm.nih.gov]

    Missing: saz
  • Hypophosphatemia

    Statistical analysis was performed by Kyowa Hakko Kirin Pharma, Inc. using SAS software, version 9.[jci.org] The study was jointly conducted with Japan's Kyowa Hakko Kirin Co. Ultragenyx jumped 19% after hours. Have breaking news sent to your inbox.[marketwatch.com] 8648 The University of Tokyo Hospital Tokyo, Japan, 113-8655 Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Ultragenyx Pharmaceutical Inc Kyowa Hakko Kirin[clinicaltrials.gov]

    Missing: saz
  • Anakinra

    Mylan Acquires License to Commercialize Adalimumab Biosimilar Mylan is partnering with Fujifilm Kyowa Kirin Biologics Co.[the-rheumatologist.org] News release: Mylan partners with Fujifilm Kyowa Kirin Biologics to commercialize biosimilar to Humira (adalimumab) . 2018 Apr 11.[the-rheumatologist.org]

    Missing: saz
  • Bacillus Megaterium

    . & Saz, A. R. Antimicrob. Ag. Chemother. 7 , 788–792 (1975). 3 Richmond, M. H. & Curtis, N. A. C. Ann. N.Y. Acad. Sci. 235 , 553–567 (1974). 4 Rolinson, G. N. Proc. R.[nature.com]

    Missing: kirin
  • Narcolepsy-Cataplexy Syndrome

    Effectiveness and safety of sodium oxybate in narcolepsy-cataplexy syndrome Carolina Alarcón-Payer , Alberto Jiménez-Morales , Ana Del Saz Caracuel , Miguel Ángel Calleja[ejhp.bmj.com]

    Missing: kirin
  • Epidermal Nevus Syndrome

    Recruitment Status : Active, not recruiting First Posted : March 30, 2016 Last Update Posted : October 11, 2018 Sponsor: Information provided by (Responsible Party): Kyowa Hakko Kirin[clinicaltrials.gov] Party: Kyowa Hakko Kirin Co., Ltd ClinicalTrials.gov Identifier: NCT02722798 History of Changes Other Study ID Numbers: KRN23-002 First Posted: March 30, 2016 Key Record[clinicaltrials.gov] Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02722798 Osaka, Japan Tokyo, Japan Seoul, Korea, Republic of Kyowa Hakko Kirin Co., Ltd Responsible[clinicaltrials.gov]

    Missing: saz
  • Mycosis Fungoides

    Mogamulizumab (Poteligeo, Kyowa Hakko Kirin Co.[healio.com] Mogamulizumab-kpkc for Mycosis Fungoides or Sézary Syndrome August 9, 2018 On Aug. 8, 2018, the Food and Drug Administration approved mogamulizumab-kpkc (Poteligeo, Kyowa Kirin[practice.asco.org] Trial results will be presented and published at a later date, according to a Kyowa Hakko Kirin Co. Ltd.-issued press release.[healio.com]

    Missing: saz
  • Organic Brain Syndrome

    Neurology 2000; 54(Supl 5): 4-9. [ Links ] Lobo A, Saz P, Marcos G, et al.[scielo.isciii.es] Ann Neurol 1991; 30: 381-390. [ Links ] Saz P, Día JL, De-la-Cámara C, et al.[scielo.isciii.es] Eur J Psychiatry 2005a; 19(1): 31-39. [ Links ] Lobo A, Saz P, Marcos G, et al.[scielo.isciii.es]

    Missing: kirin
  • Cilastatin-Imipenem

    Disclosures: Tamura: Kyowa Hakko Kirin Co., Ltd,: Consultancy. 2012 by The American Society of Hematology[bloodjournal.org]

    Missing: saz
  • Chlortetracycline

    ., Science , 113 , 273 (1951). 3 Saz, A. K., and Slie, R. B., J. Amer. Chem. Soc. , 75 , 4626 (1953). 4 Saz, A. K., and Martinez, L. M., J. Biol.[nature.com]

    Missing: kirin

Further symptoms